CM, expanding its market reach. JP Morgan upgrades the stock, projecting strong sales and a multi-billion opportunity.

With the tournament in Philadelphia, many Penn State fans are able to drive to nationals — a convenience rarer than a Leap Year.

This affirmation of AdaptHealth’s ratings indicates Moody’s expectation that the company will continue its modest organic growth, particularly in the diabetes segment, following improved operating ...

Trying to project future athletic success for a young athlete is a tricky proposition, especially when the athlete in ...

JPMorgan analyst Jessica Fye lowered the firm’s price target on Moderna (MRNA) to $33 from $40 and keeps an Underweight rating on the shares, primarily due to more conservative RSV and influenza ...

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

J.P. Morgan analyst Jessica Fye maintained a Buy rating on Insmed (INSM – Research Report) on March 14 and set a price target of $90.00. The ...

Such is the case for Alexandria’s Ezra Fye, their senior wrestler and state finalist who, just three years ago, was not enjoying the sport and was relegated to a junior varsity role for the Tigers.

In a report released on March 14, Jessica Fye from J.P. Morgan maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), ...

Odikwa was coined and used as a campaign mantra for Netumbo Nandi-Ndaitwah to become the president of Namibia.

KBRA assigns a long-term rating of AA to the State of Louisiana General Obligation Bonds, Series 2025-B and affirms the long-term rating of AA for the State's outstanding General Obligation Bonds. The ...

Detailed price information for Universal Health Services (UHS-N) from The Globe and Mail including charting and trades.